Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
All seems a bit quite...
We have the new finance guy... he will be working on next funding, possible a deal with one of the big guns..?
I'm sure a RNS is due anyway now for something..
No one likes to see a slow drift.. however we do often see when a offering is done, they always get it at market value at whatever the current price is.. a drit south makes that price more acceptable I suppose
All gone a bit quite. Don't like it when we drop below £3 a share
https://www.medrxiv.org/content/10.1101/2023.04.17.23288693v1
Exactly.. if there are no side effects of bex and only benefits then why not accelerate approval!
They pushed the covid vaccines through and it the vaccines where hot and miss with side effects.
A cancer vaccines isn't going to be taken lightly by the public. They will have to jump through all the same hoops as the rest if us.
Well he just got the job, so he will be keen on showing what he can do.
I'm expecting a cash injection soon
Not sure what next news is, apart from Putin threatening Finland for joining Nato!
Is timo losing his finish connection with the CFO now probably focusing on the US for investment?
"Faron's progression towards becoming a global biopharmaceutical company."
Is this the direction faron are heading?
James O'brian role is to get the needed funds to prove up bex.. or with his experience is it to get us listed on the US markets?
I'm sure marku said once that the evential direction they want to go is a buyout
https://www.sciencedirect.com/science/article/abs/pii/S1359644623000697?dgcid=author
Share price often lags news with faron...
Maybe an initial jump the down.. then a few days later the rise..
Let's see.
Today was big news.. to get FDA approval to move on takes alot of background work we never see.. but we are moving foward and obviously patient results from phase 2 has results pretty quick with bex plus knowing what patients bex works on... things are very good
Just to point out. Faron got tripedup with the traumakine/steroid issue.. I think they have learned their lesson..
Phase 2 needs patient selection with all boxes checked so as to have have great results!
Big pharma are watching for sure!
Great news. We'll done to the Faron team
Thanks sax
We should be getting news soon.. anyone know the timeliness?
https://twitter.com/FaronPharm/status/1635672417887461381?t=I6w-6n3cnKIJ1j8Whw--EA&s=09
We are valued at 213 million now 3.30 a share
We are looking about 5 times the share price today..
Around 15 quid a share.. sound good to me..
That's great Sophie, thank you.
"is expecting a $1bn licensing deal for bexmarilimab to be"
What would that make the share price?
Tried to sign up but they want some weird email format